These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25399848)

  • 1. Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
    Jabir NR; Firoz CK; Baeesa SS; Ashraf GM; Akhtar S; Kamal W; Kamal MA; Tabrez S
    CNS Neurosci Ther; 2015 Jan; 21(1):1-7. PubMed ID: 25399848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases.
    McKenzie JA; Spielman LJ; Pointer CB; Lowry JR; Bajwa E; Lee CW; Klegeris A
    Curr Aging Sci; 2017; 10(3):158-176. PubMed ID: 28302047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in neurodegenerative diseases: Common mechanisms and current treatment options.
    Galts CPC; Bettio LEB; Jewett DC; Yang CC; Brocardo PS; Rodrigues ALS; Thacker JS; Gil-Mohapel J
    Neurosci Biobehav Rev; 2019 Jul; 102():56-84. PubMed ID: 30995512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies.
    Fratiglioni L; Wang HX
    Behav Brain Res; 2000 Aug; 113(1-2):117-20. PubMed ID: 10942038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease.
    Magalingam KB; Radhakrishnan A; Ping NS; Haleagrahara N
    Biomed Res Int; 2018; 2018():3740461. PubMed ID: 29707568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.
    Paolini Paoletti F; Simoni S; Parnetti L; Gaetani L
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress and antioxidants in neurodegenerative diseases.
    Rao AV; Balachandran B
    Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
    Majd S; Power JH; Grantham HJ
    BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.